Life-saving early detection of lung cancer is just a breath away

Screening for lung cancer may soon be as routine as having your blood pressure taken and as convenient as picking up your prescriptions, thanks to a breakthrough innovation by a Moncton-based company. 

As a result of the AI and machine learning expertise of University of New Brunswick biomedical engineering master’s student and Mitacs intern Robyn Larracy, biotech firm Picomole Inc. has developed a first-of-its-kind screening tool that makes lung cancer detection as simple as breathing into a tube. The innovation is expected to be commercialized as early as 2024. 

Tech pioneer traces roots through partnership

A recipient of the World Economic Forum 2015 Technology Pioneer Award, Vancouver-based quantum computing company 1QBit is a leader among the most promising technology companies. The company works closely with Fortune 500 clients and leading hardware providers to solve problems in the areas of optimization, simulation, and machine learning. 

Collaboration with biotech incubator creates jobs for researchers

For Toronto-based Dose Biosystems, a focus on researching and developing the next generation of probiotics brings a hiring challenge: finding and onboarding highly specialized talent. Coming directly from doctoral programs, new employees encounter an unfamiliar environment that requires new skills and different ways of working.

Pivoting from bones to bread during COVID-19

Across Canada, businesses and organizations grappling with the impact of COVID-19 are getting support from an unexpected resource: top local business students.

Thanks to the recently launched Business Strategy Internship (BSI) program, Mitacs helps match students from top schools with employers looking for support to manage and grow their operations in an environment disrupted by the pandemic.

Best gift ever: a fully staffed lab-in-a-box

There are few words more painful to imagine than “your child has cancer.”

Overhearing these life-altering words prompted Mitacs research intern Taylor Jamieson-Datzkiw to pursue a career in pediatric oncology — that is, cancer treatments for children and young adults.

Using 3D printing to accelerate production of protective gear during COVID-19

With the onset of the COVID-19 crisis, CAMufacturing Solutions Inc. knew they needed to bring their expertise in additive manufacturing, or 3D printing, to support the rising demand for quick production of personnel protective equipment (PPE) for the health care community.

Young entrepreneurs improve medical storage for reliable transportation

As of May 27, 2020, there have been 2,925,466 infected COVID-19 patients reported worldwide, with a total of 355,727 deaths. The rapid progression of the COVID-19 pandemic has raised concerns regarding the short supply of medical equipment needed to control the rate of transmission and mortality. In most developing countries, transporting vaccines can be difficult without the proper storage technologies, since vaccines and equipment can spoil in high temperatures.

Mitacs research fellow helps pivot decontamination from fruit to N95 masks

When postdoctoral fellow Mahdiyeh Hasani of University of Guelph came to Canada in 2017 and began working with Professor Keith Warriner to decontaminate produce, she had no idea that in just a few years COVID-19 would dramatically change the world — and the impact of her research.

How Internet of Things can support radio infrastructure

In urgent situations like natural disasters — or even the current pandemic — Canadian first-response teams rely on mobile radio systems to communicate in a fast and secure way. Manufacturers globally also use radio systems in their production plants. Enabling radio communications requires a complex infrastructure with hundreds of thousands of radio repeater sites spread across North America and the globe.

Intern works to protect IP for COVID-19 vaccine development

According to the Public Health Agency of Canada, the total number of COVID-19 cases reached a high of 71,486 as of May 13, 2020 — with Ontario and Quebec collectively accounting for 83% of all cases and 92% of the Canadian death toll. With a mortality rate of 3.4%, COVID-19 has created an unprecedented — and growing — demand for a vaccine.

Pages